Kernel x Cybin Announce Ketamine Pilot Results

preview_player
Показать описание
Kernel & Cybin are announcing pilot results from a feasibility study evaluating Kernel’s quantitative neuroimaging technology, Flow, to measure cortical hemodynamics of the brain while experiencing ketamine. Kernel Founder/CEO Bryan Johnson volunteered as the first pilot participant in the study.

Early data from the piloting suggested that ketamine-induced changes in the functional connectivity of the subject's brain lingered for several days after administration. Kernel Flow successfully measured the neuro-effect of ketamine over 11 days (baseline at Days 1-5, dosing at Day 6, follow-up at Days 7-11), and confirmed changes in functional connectivity that are consistent with current scientific research.

Psychedelics have unique powers to improve mental wellness. Flow gives its potential by introducing a data-driven approach for discovery, protocol development and personalization. We’re excited to report the pilot results of a longitudinally rich dataset of brain activity before, during and after a ketamine-induced altered-state experience. The quality of the data recorded with Flow may lead to a better understanding of the neuro effects of psychedelics on the brain and help to advance these powerful new therapies for patients.

Our brain knows things that we don’t. Wisdom we want, need and must know. Now we can.

Follow Kernel:
Kernel has effectively turned a $3m fMRI machine into a light wearable helmet. We are a world-class team of engineers, neuroscientists, physicists and operators working to make measurement of the brain and mind mainstream.

Follow Bryan Johnson:
Bryan sold his company Braintree Venmo to PayPal for $800 million which he used to fund Kernel, builder of the world’s most versatile next-generation, non-invasive brain-machine interface.

If you liked this video make sure to subscribe to our channel to stay up to date.
Рекомендации по теме
Комментарии
Автор

So excited to see where this can go! Kernal use cases are wide and so important for everyone's well-being. Well done Bryan and team.👍

greenhoodie
Автор

1:50
Don't get annual dental X-Rays if not specifically indicated.

Pyriphlegeton
Автор

I need to see more studies, this is too cool!

werdeyo
Автор

Could you please begin to promote the utilization of the kernel in epilepsy research?

geosmi
Автор

wow. its amazing that you managed to create a device that shows brain connections and its not intrusive

andreivasiliu
Автор

biggest question is: Is he still doing this?

frankcastaigno
Автор

Super excited about this technology and what we can learn from psychedelic therapies 🧠

sofiaqt
Автор

Very interesting! Next trial with DMT? Buddhist masters of meditation? Lucid Dreamers?

sinanrobillard
Автор

Ketamine really fked me up, caused depersonalization, OCD, depression... lasted for 2 weeks the effect, never ever again, it was pure hell

negvey
Автор

I wish I was a test subject. I need ketamine to treat my Borderline Personality Disorder.

pandoraeeris
Автор

You gotta colab with elon the fastest as possible

gabrieldias-jdtn
Автор

bruh ketamine is a horse tranquiliser, dat shii just makes a nice dent in ya brain, like a barral of liquere ...not a psychodelic

devileclique
Автор

What kind of life is this? I fell sorry for him.

m
visit shbcf.ru